REVB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.22%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $34,582.50

Revelation Biosciences Insider Trading History Chart

Revelation Biosciences Share Price & Price History

^$1.59

▼ -0.03 (-1.85%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Kiss of death from Joe Biden

From Porter & Company | Ad

I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but they do not care.

I have uncovered a bombshell that changes everything… and threatens everything.

Revelation Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/8/2023	George F. Tidmarsh	Director	Sell	925	$15.60	$14,430.00
10/16/2023	George F Tidmarsh	Director	Sell	365	$19.80	$7,227.00	1,403
9/28/2023	George F Tidmarsh	Director	Sell	47	$20.70	$972.90	1,403
9/18/2023	George F Tidmarsh	Director	Sell	133	$22.20	$2,952.60	1,311
9/14/2023	George F Tidmarsh	Director	Sell	400	$22.50	$9,000.00	1,761
4/17/2023	George F Tidmarsh	Director	Buy	883	$34.80	$30,728.40	1,328
2/25/2022	George F Tidmarsh	Director	Buy	19	$1,680.00	$31,920.00

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”

From Paradigm Press | Ad

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

SEC Filings (Institutional Ownership Changes) for Revelation Biosciences (NASDAQ:REVB)

12.80% of Revelation Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Revelation Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2023	Sabby Management LLC	403,233	$0.28M	0.2%	+14.2%	6.401%
7/27/2023	Virtu Financial LLC	66,972	$63K	0.0%	N/A	1.107%
5/19/2023	Anson Funds Management LP	213,509	$0.28M	0.0%	N/A	3.700%
5/16/2023	Altium Capital Management LP	37,198	$48K	0.0%	N/A	0.644%
5/12/2022	Monashee Investment Management LLC	817,562	$0.93M	0.3%	N/A	5.420%

Data available starting January 2016

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.

Today's Range

Now: $1.59

$1.58

$1.64

50 Day Range

MA: $1.95

$1.61

$2.40

52 Week Range

Now: $1.59

$1.52

$28.20

Volume

19,255 shs

Average Volume

459,592 shs

Market Capitalization

$2.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.21

Who are the company insiders with the largest holdings of Revelation Biosciences?: Revelation Biosciences' top insider investors include:
George F Tidmarsh (Director)
George F Tidmarsh (Director)
Learn More about top insider investors at Revelation Biosciences.